Search Within

Nima Almassi

Formats
  1. Journal Article (13)
  2. Meeting Abstract (11)
  3. Correspondence (1)
  4. Review (1)
Groups
  1. Surgery (24)
  2. Urology (24)
  3. Department of Medicine (21)
  4. Genitourinary Oncology Service (21)
  5. Solid Tumor Oncology Division (21)
  6. Department of Pathology and Laboratory Medicine (16)

More Groups

People
  1. Eugene Pietzak (16)
  2. Hikmat Al-Ahmadie (16)
  3. Bernard Bochner (15)
  4. David Solit (14)
  5. Gopakumar Iyer (13)
  6. Jonathan Rosenberg (13)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (15)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Clinical Cancer Research (3)
  3. BJU International (2)
  4. Journal of Urology (2)
  5. Cell Reports (1)
  6. Current Opinion in Urology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Elsevier Science, Inc. (4)
  3. American Association for Cancer Research (3)
  4. Wiley Blackwell (3)
  5. Lippincott Williams & Wilkins (2)
  6. Nature Publishing Group (2)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ileal conduit or orthotopic neobladder: Selection and contemporary patterns of use
    Journal Article

    Almassi, N.; Bochner, B. H.
    Current Opinion in Urology (2020)

    Fulltext@MSK | Save
  • Genomic landscape of non-invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Kennedy, J.; Clinton, T.; Almassi, N.; Pietzak, E.; Bochner, B.; Fine, S.; Gopalan, A.; Chen, Y. B.; Sarungbam, J.; Sirintrapun, S. J.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Inverted urothelial papilloma and urothelial carcinoma with inverted growth are histologically and molecularly distinct entities
    Review

    Almassi, N.; Pietzak, E. J.; Sarungbam, J.; Tickoo, S. K.; Reuter, V. E.; Solit, D. B.; Al-Ahmadie, H. A.
    Journal of Pathology (2020)

    Fulltext@MSK | Save
  • HSD3B1 and overall survival (OS) in men with low-volume (LV) metastatic prostate cancer (PCa) treated with androgen deprivation therapy (ADT) or chemohormonal therapy in the CHAARTED Randomized trial
    Meeting Abstract

    Hearn, J. W. D.; Sweeney, C.; Almassi, N.; Reichard, C. A.; Reddy, C. A.; Hobbs, B.; Jarrard, D. F.; Chen, Y. H.; Dreicer, R.; Garcia, J. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The patient's perspective on blue light flexible cystoscopy: Insight from a prospective clinical study
    Journal Article

    Almassi, N.; Pietzak, E.
    Translational Andrology and Urology (2018)

    Fulltext@MSK | Save